IONS

Ionis Pharmaceuticals

• TipRanks·1d ago

  Nike downgraded, IBM initiated: Wall Street’s top analyst calls

• Reuters·1d ago

  IONIS PHARMACEUTICALS INC <IONS.O>: RAYMOND JAMES RESUMES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $104

• Dow Jones·1d ago

  Ionis Pharmaceuticals Price Target Raised to $111.00/Share From $100.00 by B of A Securities

• Dow Jones·1d ago

  Ionis Pharmaceuticals Is Maintained at Buy by B of A Securities

• Benzinga·1d ago

  B of A Securities Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $111

• TipRanks·2d ago

  Ionis Pharmaceuticals price target raised to $111 from $100 at BofA

• Reuters·2d ago

  IONIS PHARMACEUTICALS INC <IONS.O>: BOFA GLOBAL RESEARCH RAISES PRICE OBJECTIVE TO $111 FROM $100

• TipRanks·2d ago

  Analysts Are Bullish on These Healthcare Stocks: EDAP TMS (EDAP), Ionis Pharmaceuticals (IONS)

• Reuters·2d ago

  U.S. RESEARCH ROUNDUP-Comstock Resources, Trustmark, Viasat

• TipRanks·3d ago

  Ionis Extends Donidalorsen Into Children: What the New HAE Trial Means for Investors

• TipRanks·3d ago

  Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Corbus Pharmaceuticals (CRBP) and Artivion (AORT)

• Seeking Alpha·5d ago

  Rare Stock Picks In March 2026 - From 23 Discerning Analysts

• Simply Wall St·5d ago

  Will Priority FDA Review of Zilganersen and Tryngolza Pricing Shift Ionis Pharmaceuticals' (IONS) Narrative

• Simply Wall St·04/04 00:27

  Assessing Ionis Pharmaceuticals (IONS) Valuation After FDA Priority Review for Zilganersen

• Reuters·04/02 23:44

  Ionis EVP Shannon Devers disposes of $0.5 million common shares